Foxo Technologies Signs $3.25M M&A Deal with Ludwig Enterprises, Inc.
FOXO Technologies entered into definitive agreements to acquire 5,000,000 shares of Ludwig Enterprises preferred stock, representing approximately 71.43% of the outstanding preferred stock and providing voting control. The total consideration includes $2.75 million in new Series F Preferred Stock and $0.5 million in cash to acquire preferred shares and outstanding notes. Ludwig is a genomic technology company developing mRNA biomarkers for detecting inflammation-related chronic diseases.
- Value
- $3.25M
- Counterparty
- Ludwig Enterprises, Inc.